Continuous manufacturing of CAR-T cells for HIV treatment enabled by real-time monitoring and microfluidic technologies Grant

Continuous manufacturing of CAR-T cells for HIV treatment enabled by real-time monitoring and microfluidic technologies .

date/time interval

  • September 1, 2022 - June 30, 2023

subcontracted through

sponsor award ID

  • Sub No. OS00001066; PO# SPC-003044

contributor